Heinz‐Wolfram Bernd

2.6k total citations · 1 hit paper
23 papers, 1.0k citations indexed

About

Heinz‐Wolfram Bernd is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Heinz‐Wolfram Bernd has authored 23 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 14 papers in Oncology and 6 papers in Genetics. Recurrent topics in Heinz‐Wolfram Bernd's work include Lymphoma Diagnosis and Treatment (17 papers), Viral-associated cancers and disorders (9 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Heinz‐Wolfram Bernd is often cited by papers focused on Lymphoma Diagnosis and Treatment (17 papers), Viral-associated cancers and disorders (9 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Heinz‐Wolfram Bernd collaborates with scholars based in Germany, Switzerland and United States. Heinz‐Wolfram Bernd's co-authors include Alfred C. Feller, Wolfram Klapper, Peter Mӧller, German Ott, Harald Stein, Markus Loeffler, Martin‐Leo Hansmann, Andreas Rosenwald, Michael Hummel and Marita Ziepert and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Heinz‐Wolfram Bernd

22 papers receiving 991 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma

2013 372 citations Heike Horn, Marita Ziepert et al. Blood profile →

Peers

Countries citing papers authored by Heinz‐Wolfram Bernd

Since Specialization

Citations

This map shows the geographic impact of Heinz‐Wolfram Bernd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heinz‐Wolfram Bernd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heinz‐Wolfram Bernd more than expected).

Fields of papers citing papers by Heinz‐Wolfram Bernd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heinz‐Wolfram Bernd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heinz‐Wolfram Bernd. The network helps show where Heinz‐Wolfram Bernd may publish in the future.

Co-authorship network of co-authors of Heinz‐Wolfram Bernd

This figure shows the co-authorship network connecting the top 25 collaborators of Heinz‐Wolfram Bernd. A scholar is included among the top collaborators of Heinz‐Wolfram Bernd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heinz‐Wolfram Bernd. Heinz‐Wolfram Bernd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Age‐ and gender‐specific molecular characteristics of diffuse large B‐cell lymphoma: Results from clinical trials of the DSHNHL/GLA 2025 ·HemaSphere ·Katrin S. Kurz, (unknown), Markus Kreuz, Marita Ziepert, Annette M. Staiger, Thomas F.E. Barth, Peter Mӧller, Heinz‐Wolfram Bernd, Alfred C. Feller, Julia Richter, Wolfram Klapper, Harald Stein, Sylvia Hartmann, Martin‐Leo Hansmann, Lorenz Trümper, Markus Loeffler, Norbert Schmitz, Andreas Rosenwald, German Ott, Heike Horn, (unknown)	0
2	Tumour cell characteristics and microenvironment composition correspond to clinical presentation in newly diagnosed nodular lymphocyte‐predominant Hodgkin lymphoma 2022 ·British Journal of Haematology ·Sylvia Hartmann, (unknown), Katrin Bankov, (unknown), Martin‐Leo Hansmann, Andreas Rosenwald, Heinz‐Wolfram Bernd, Alfred C. Feller, German Ott, Peter Mӧller, Harald Stein, Wolfram Klapper, Peter Borchmann, Andreas Engert, Dennis A. Eichenauer	14
3	Performance of international prognostic indices in plasmablastic lymphoma: a comparative evaluation 2021 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Hartmut Merz, Heinz‐Wolfram Bernd, Veronica Bernard, Axel Künstner, Hauke Busch, Nikolas von Bubnoff, Alfred C. Feller, Hanno M. Witte, Niklas Gebauer	6
4	Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways 2021 ·Blood Advances ·Hanno M. Witte, Axel Künstner, (unknown), Heinz‐Wolfram Bernd, Veronica Bernard, (unknown), Hartmut Merz, Nikolas von Bubnoff, Hauke Busch, Alfred C. Feller, Niklas Gebauer	18
5	Histopathological growth patterns in patients with advanced nodular lymphocyte‐predominant Hodgkin lymphoma treated within the randomized HD18 study: a report from the German Hodgkin Study Group 2021 ·British Journal of Haematology ·Dennis A. Eichenauer, (unknown), Stefanie Kreissl, Helen Goergen, Michael Fuchs, Bastian von Tresckow, Andreas Rosenwald, Wolfram Klapper, Martin‐Leo Hansmann, Peter Mӧller, Heinz‐Wolfram Bernd, Alfred C. Feller, Andreas Engert, Peter Borchmann, Sylvia Hartmann	8
6	The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma 2019 ·American Journal of Hematology ·Sylvia Hartmann, Annette Plütschow, Anja Mottok, Heinz‐Wolfram Bernd, Alfred C. Feller, German Ott, Sergio Cogliatti, Falko Fend, Leticia Quintanilla-Martı́nez, Harald Stein, Wolfram Klapper, Peter Mӧller, Andreas Rosenwald, Andreas Engert, Martin‐Leo Hansmann, Dennis A. Eichenauer	24
7	Hodgkin's lymphoma as a rare variant of Richter's transformation in chronic lymphocytic leukemia: A case report and review of the literature 2016 ·Molecular and Clinical Oncology ·(unknown), Heinz‐Wolfram Bernd, Carsten Bokemeyer, Walter Fiedler	6
8	MicroRNA Profiling of Low-Grade and Transformed Nodal Marginal Zone Lymphoma Reveals a Similar Signature Pattern Distinct from Diffuse Large B Cell Lymphoma 2014 ·Acta Haematologica ·Niklas Gebauer, Christoph Thorns, Veronica Bernard, Andrea Senft, Arne Schillert, Hartmut Merz, Alfred C. Feller, Heinz‐Wolfram Bernd	4
9	Tumor Cell Proliferation (Ki-67 Index) Overcomes Cytology and Growth Pattern As Prognostic Factor in Mantle-Cell Lymphoma – Results from Randomized Trials of the European MCL Network 2014 ·Blood ·Eva Hoster, Andreas Rosenwald, Françoise Berger, Heinz‐Wolfram Bernd, Sylvia Hartmann, Christoph Loddenkemper, Thomas F.E. Barth, Nicole Brousse, Stefano Pileri, Grzegorz Rymkiewicz, Roman Kodet, Michael Unterhalt, Hanneke C. Kluin‐Nelemans, Olivier Hermine, Wolfgang Hiddemann, Martin Dreyling, Wolfram Klapper	5
10	The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG) 2013 ·Blood ·Sylvia Hartmann, Dennis A. Eichenauer, Annette Plütschow, Anja Mottok, Roshanak Bob, Karoline Koch, Heinz‐Wolfram Bernd, Sergio Cogliatti, Michael Hummel, Alfred C. Feller, German Ott, Peter Mӧller, Andreas Rosenwald, Harald Stein, Martin‐Leo Hansmann, Andreas Engert, Wolfram Klapper	112
11	MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma breakdown → 2013 ·Blood ·Heike Horn, Marita Ziepert, (unknown), Thomas F.E. Barth, Heinz‐Wolfram Bernd, Alfred C. Feller, Wolfram Klapper, Michael Hummel, Harald Stein, Martin‐Leo Hansmann, (unknown), Peter Mӧller, Sergio Cogliatti, Michael Pfreundschuh, Norbert Schmitz, Lorenz Trümper, Reiner Siebert, Markus Loeffler, Andreas Rosenwald, German Ott	372
12	Cell Proliferation (Ki-67) As Prognostic Marker in Mantle Cell Lymphoma. 2012 ·Blood ·Eva Hoster, Wolfram Klapper, Andreas Rosenwald, Heinz‐Wolfram Bernd, Sylvia Hartmann, Christoph Loddenkemper, Thomas F.E. Barth, Wolfgang Hiddemann, Michael Unterhalt, Hanneke C. Kluin‐Nelemans, Olivier Hermine, Martin Dreyling	4
13	Deregulation of a distinct set of microRNAs is associated with transformation of gastritis into MALT lymphoma 2012 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Christoph Thorns, (unknown), Veronica Bernard, Andrea Senft, Silke Szymczak, Alfred C. Feller, Heinz‐Wolfram Bernd	38
14	Basal cell carcinoma with neuroendocrine differentiation arising in a scar: A case report 2009 ·Dermatology Online Journal ·Manuela Krokowski, J. Hoch, Alfred C. Feller, Heinz‐Wolfram Bernd, Christoph Thorns, Stefan Krueger	12
15	A cytomorphological and immunohistochemical profile of aggressive B-cell lymphoma: high clinical impact of a cumulative immunohistochemical outcome predictor score 2009 ·Journal of Hematopathology ·Sylvia Höller, Heike Horn, Andreas Lohr, Uwe Mäder, Tiemo Katzenberger, Jörg Kalla, Heinz‐Wolfram Bernd, Philip Went, Michaela Ott, Hans Konrad Müller‐Hermelink, Andreas Rosenwald, German Ott	5
16	BCL6-translocations affect the phenotype of follicular lymphomas only in the absence of t(14;18)IgH/BCL2. 2009 ·PubMed ·(unknown), (unknown), Torge Huckhagel, Heinz‐Wolfram Bernd, Manuela Krokowski, Hartmut Merz, Alfred C. Feller, Christoph Thorns	19
17	MicroRNA signatures characterize diffuse large B‐cell lymphomas and follicular lymphomas 2008 ·British Journal of Haematology ·(unknown), Kai P. Hoefig, Dirk Repsilber, Christoph Thorns, Marita Ziepert, (unknown), (unknown), Markus Loeffler, Wolfram Klapper, Michael Pfreundschuh, András Matolcsy, Heinz‐Wolfram Bernd, (unknown), Hartmut Merz, Alfred C. Feller	154
18	Sarcoma of follicular dendritic cells with features of sinus lining cells—a new subtype of reticulum cell sarcoma? 2008 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Manuela Krokowski, Hartmut Merz, Christoph Thorns, Heinz‐Wolfram Bernd, (unknown), A. Le Tourneau, J Diébold, Alfred C. Feller	5
19	Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials 2008 ·Blood ·Wolfram Klapper, Monika Szczepanowski, Birgit Burkhardt, Hilmar Berger, Maciej Rosołowski, Stefan Bentink, Carsten Schwäenen, Swen Weßendorf, Rainer Spang, Peter Mӧller, Martin L. Hansmann, Heinz‐Wolfram Bernd, German Ott, Michael Hummel, Harald Stein, Markus Loeffler, Lorenz Trümper, Martin Zimmermann, Alfred Reiter, Reiner Siebert	79
20	Tumor Sclerosis but Not Cell Proliferation or Malignancy Grade Is a Prognostic Marker in Advanced-Stage Follicular Lymphoma: The German Low Grade Lymphoma Study Group 2007 ·Journal of Clinical Oncology ·Wolfram Klapper, Eva Hoster, (unknown), Carsten Schrader, Dirk Janssen, Markus Tiemann, Heinz‐Wolfram Bernd, Olaf Determann, Martin‐Leo Hansmann, Peter Mӧller, Alfred C. Feller, Harald Stein, Hans‐Heinrich Wacker, Martin Dreyling, Michael Unterhalt, Wolfgang Hiddemann, German Ott	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact